Fig 1.
Out of 83 patients analyzed at baseline CCTA, 68 patients were included at follow-up CCTA.
Table 1.
Patient characteristics at baseline.
Table 2.
CCTA findings, lipids and inflammatory markers at baseline and follow-up (per-patient-level).
Fig 2.
Mean change in plaque volume in the 3 IJD groups.
Data shown as mean change in soft/mixed, calcified and total plaque volume (mm3). The soft/mixed plaque was over-all reduced, and calcified and total plaque volume increased in all groups. The plaque alterations are highest in the AS-group. RA:rheumatoid arthritis, AS:ankylosing spondylitis, PsA:psoriatic arthritis.
Table 3.
Lipid status and CAD-progression in patients with and not with LDL-c ≤ 1.8mmol/l.
Table 4.
Associations between progression of CAC (A), total plaque volume (B), soft/mixed plaque volume (C) with lipids, inflammatory markers and sDMARDS/bDMARDS.
Fig 3.
Difference in lipids and age between percentiles of increase in total plaque volume (mm3).
The reference line is set to median in all variables. LDL-c; low density lipoprotein-cholesterol, HDL-c; high density lipoprotein-cholesterol.